Bionano Genomics reported a GAAP loss of $72.435 million for 2021, up 76.2% from $41.106 million in the previous year. Revenue increased 2.1-fold to $17.981 million from $8.503 million a year earlier.
Bionano Genomics reported a GAAP loss of $72.435 million for 2021, up 76.2% from $41.106 million in the previous year. Revenue increased 2.1-fold to $17.981 million from $8.503 million a year earlier. 
ir.bionanogenomics.com
English (US) 